Sharenet Sites 
Sharenet Sites
Summarised results for the year ended 31 December 2025
AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
("AfroCentric" or "the Company")
Summarised results for the year ended 31 December 2025
Introduction to the AfroCentric Group
AfroCentric is a BEE level 1, JSE listed investment holding company, committed to transforming and
advancing healthcare access and affordability across Southern Africa. Through our diversified portfolio of
subsidiaries, we deliver integrated health management solutions, including medical aid administration,
managed care, medicine provision, wellness services and digital health innovations. The Group plays a
pivotal role across the public and private sectors, driving efficiencies, health outcomes and enabling
sustainable healthcare delivery. Our strategic focus remains on expanding our footprint, leveraging
technology and clinical innovation and fostering partnerships that support inclusive, value-based
healthcare for all.
The Board presents a summary of the Company's results for the year ended 31 December 2025.
Salient Features
% Year ended Six months
change 31 December ended 31
2025 December
2024
Total revenue from contracts with customers from 93.9 7 303.2 3 765.4
continuing operations (R' million)
(Loss)/Profit before tax from continuing operations (>100) (531.9) 225.1
(R' million)
(Loss)/Profit from continuing operations (R' million) (>100) (645.9) 167.8
Basic loss (R' million) (>100) (1 274.2) (125.9)
Headline earnings (R' million) >100 117.1 31.9
Basic loss (cents per share) (>100) (151.55) (14.96)
Headline earnings (cents per share) >100 13.92 3.80
Weighted average number of ordinary shares 840.75 million 841.09 million
Net asset value per share (cents per share) (40.7) 231 390
Dividend declared (cents per share) - 6
The annual financial statements for the year ended 31 December 2025 were audited by Z.A Beseti of KPMG
Inc, who issued an unmodified opinion.
Full Announcement
This short-form announcement is the responsibility of the Directors of the Company and is a summary of
the information in the full announcement and does not contain full or complete details. The full
announcement is available for viewing on the following websites:
Company's website: www.afrocentric.za.com/investor-centre/.
JSE website: https://senspdf.jse.co.za/documents/2026/JSE/ISSE/ACT/Dec2025.pdf
Management will host a virtual investor presentation tomorrow, Wednesday, 04 March 2026 at 10:00
SAST. The webcast will be accessible at www.corpcam.com/AfroCentric04032026.
This short-form announcement does not contain full or complete details and any investment decision by
investors and/or shareholders should be based on consideration of the information contained in the
summarised results for the year ended 31 December 2025, copies of which are also available for inspection at
the Company's offices on workdays during business hours (at no charge) or on request from the company
secretary by email: lebohang.mpumlwana@afrocentrichealth.com
On behalf of the Board
Prof ATM Mokgokong Mr GN van Wyk
Chairman Group Chief Executive Officer
Johannesburg
4 March 2026
JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited
Date: 04-03-2026 07:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
